How is targeted therapy different from immunotherapy?

How are targeted therapies different from immunotherapies?

So targeted therapies are going to act more directly on the cell itself, whereas immunotherapies are going to work more on the cells that help to either support the myeloma cells, you know, that are unfortunately helping the myeloma cells proliferate or they're going to help supercharge our immune system to attack the myeloma cells. But in general, immunotherapy does not actively attack the myeloma itself. They either attack the supportive cells or they supercharge our body to help attack the myeloma.

Can you combine an immunotherapy with a targeted therapy?

So combination therapy is really core of myeloma therapy. Using a single agent or a single class of agents is helpful to an extent, but oftentimes is only minimally helpful for longer periods of time. By using multiple classes of agents in combination is when we really start to see the deeper and the more durable or longer term remissions and benefits for our myeloma patients.